Jason Tardio
Net worth: 18 715 $ as of 30/05/2026
Net worth: 18 715 $ as of 30/05/2026
Mr. Jason Tardio is a President & Chief Operating Officer at Immunic, Inc. Mr. Tardio was previously employed as a Chief Operating Officer by Ovid Therapeutics, Inc., a VP & Head-Multiple Sclerosis Franchise by Novartis, Inc., and a General Manager & Managing Director by Biogen, Inc. He received his undergraduate degree from The College of New Jersey and an MBA from St. Joseph's University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IMMUNIC, INC. 0.01% | 25/05/2026 | 1,251 ( 0.01% ) | 18 715 $ | 30/05/2026 |
| Companies | Position | Start |
|---|---|---|
| IMMUNIC, INC. | President | 11/07/2024 |
| Companies | Position | End |
|---|---|---|
| OVID THERAPEUTICS INC. | Chief Operating Officer | 10/07/2024 |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco, CA. | Corporate Officer/Principal | 31/10/2019 |
| BIOGEN INC. | Corporate Officer/Principal | 31/08/2018 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco, CA. | Health Technology |
Ovid Therapeutics, Inc.
Ovid Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides medicines to children and adults with neurological disorders | Health Technology |
The College of New Jersey
The College of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Joseph's University
St. Joseph's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunic, Inc.
Immunic, Inc. Pharmaceuticals: MajorHealth Technology Develops oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions